New risk statements required for benzocaine product labelsNew statements focus on the risk of methemoglobinemia and how to recognize its signs and symptoms. OTC Market Report 2012: Pain reliefPain relief options add to pharmacies’ bottom line. Do you really need that opioid? Fibromyalgia pain responds to low-dose naltrexone Custom compounded drug has ‘outstanding’ side-effect profile Rehab program tackles substance abuse, comorbid pain Mayo Clinic approach uses cognitive-behavioural therapy, exercise, other modalities Ontario College advice on managing switch from OxyContin Advisory follows fatality resulting from change in prescription from OxyContin to another opioid analgesic. Tips for self-treating minor pain Pain management is enhanced when pharmacologic therapies are combined with physical and psychological approaches. Choosing the right topical pain reliever Natural alternatives for clients seeking pain relief. Calculators for who should get low-dose ASA wildly divergent Various tools defined from 26% to 78% of same group as candidates for treatment Low-dose ASA over-prescribed Yet study shows it is hard to change FPs’ prescribing of low-dose ASA First Previous 30 31 32 33 34 Next Last
